LBP, I agree it is frustrating to see these things put on hold without any visibility. And these matters are generally not discussed at these events. Perhaps in the future, we can mobilize the patient community to advocate and present at the FDA conferences!!!
I did attend an Active-L session, and I learned about five different US trial centers that are open (info pending). I have a call into Aesculap on this issue.
|